Tyra Biosciences (TYRA) Total Liabilities (2020 - 2026)

Tyra Biosciences has reported Total Liabilities for 7 years, with the latest figure at $24.5 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 22.68% year-over-year to $24.5 million; the trailing twelve-month figure through Mar 2026 stood at $24.5 million (up 22.68% YoY), and the FY2025 full-year result was $23.4 million, up 14.82% from the prior year.
• Total Liabilities for Q1 2026 stood at $24.5 million, up from $23.4 million in the prior quarter.
• The five-year high for Total Liabilities was $24.5 million in Q1 2026, with the low at $6.3 million in Q1 2023.
• Historically, Total Liabilities has averaged $15.7 million across 5 years, with a median of $16.4 million in 2024.
• Annual changes were most pronounced in 2022 — Total Liabilities plunged 63.54% — and 2023, when it soared 158.56%.
• Tyra Biosciences' Total Liabilities stood at $8.4 million in 2022, then surged by 158.56% to $21.6 million in 2023, then decreased by 5.5% to $20.4 million in 2024, then grew by 14.82% to $23.4 million in 2025, then increased by 4.41% to $24.5 million in 2026.
• The last three Total Liabilities figures came in at $24.5 million (Q1 2026), $23.4 million (Q4 2025), and $21.3 million (Q3 2025), per Business Quant data.